HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1097314Generated: November 1, 2026
Sodium Iodide → 4-imidazo[1,2-b]pyridazin-7-yl-1-(3-piperidin-1-yl-propyl)-1H-pyridin-2-one
https://huagongshe.com/reaction/1097314
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | N-(3-chloropropyl)piperidine hydrochloride | HCID 79624 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | HCID 178515730 | HCID 178515730 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 4-imidazo[1,2-b]pyridazin-7-yl-1-(3-piperidin-1-yl-propyl)-1H-pyridin-2-one | HCID 59443509 | — |
Reaction Steps
4-Imidazo[1,2-b]pyridazin-7-yl-pyridin-2-ol (1 eq, 0.17 mmol, 36 mg), 1-(3-chloropropyl)piperidine monohydrochloride (1.5 eq, 0.255 mmol, 52 mg) and sodium iodide (1.5 eq, 0.254 mmol, 37.9 mg) are dissolved in DMF (1 ml) and heated at 60° C. for 16 h to give a black solution. The reaction mixture is then poured into aq. sat. NaHCO3 and the organic phase is extracted with CH2Cl2. The organic phase is washed with brine, dried over MgSO4, filtered and evaporated to dryness to afford 4-imidazo[1,2-b]pyridazin-7-yl-1-(3-piperidin-1-yl-propyl)-1H-pyridin-2-one; [M+H]+=338
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08143253B2 |
|---|
| Source dataset | uspto-grants-2012_03 |
|---|
| ORD ID | ord-a2b49cd9be2a42cbbede1bc38ca88ac7 |
|---|
| Source note | uspto-grants-2012_03 |
|---|